Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity OncoSil Medical Limited ABN/ARBN Financial year ended: 89 113 824 141 30 June 2026 Our...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Appendix 4E and Annual Report
- Change in substantial holding
- Change in substantial shareholding for OSL
- Application for quotation of securities - OSL
- Investor Webinar Presentation
Later from OncoSil Medical
- OncoSil submits US Reimbursement Application
- OncoSil submits US Reimbursement Application (Updated)
- Proposed issue of securities - OSL
- OSL Secures $5.6 million from Major Institutional Investors
- 100th Patient Treated with OncoSil device in Spain
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical